We observed significant association with overexpression of WDFY3‐AS2 (Fig. 5G) and downregulation of RP11‐161M6.2 in stage 2 of breast cancer based on TANRIC analysis indicating them as potential early prognostic markers (Fig. 5G,J). Here, WDFY3 is linked to breast carcinoma.